Four-year natural clinical course of pulmonary epithelioid hemangioendothelioma without therapy

Akira Haro, Genkichi Saitoh, Sadafumi Tamiya, Akira Nagashima

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Pulmonary epithelial hemangioendothelioma is a rare low to intermediate malignant vascular tumor originating from vascular endothelial cells. The therapy for this disease, if possible, is surgical resection. However, there is no standard treatment for patients with multiple unresectable lesions. We present the case of a 42-year-old woman treated with a natural clinical course of hemangioendothelioma for four years without therapy. The nodules have increased in number and size extremely slowly, and the patient is alive and asymptomatic four years after diagnosis.

Original languageEnglish
Pages (from-to)544-547
Number of pages4
JournalThoracic Cancer
Volume6
Issue number4
DOIs
Publication statusPublished - Jul 1 2015

Fingerprint

Epithelioid Hemangioendothelioma
Hemangioendothelioma
Lung
Blood Vessels
Therapeutics
Endothelial Cells
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Four-year natural clinical course of pulmonary epithelioid hemangioendothelioma without therapy. / Haro, Akira; Saitoh, Genkichi; Tamiya, Sadafumi; Nagashima, Akira.

In: Thoracic Cancer, Vol. 6, No. 4, 01.07.2015, p. 544-547.

Research output: Contribution to journalArticle

Haro, Akira ; Saitoh, Genkichi ; Tamiya, Sadafumi ; Nagashima, Akira. / Four-year natural clinical course of pulmonary epithelioid hemangioendothelioma without therapy. In: Thoracic Cancer. 2015 ; Vol. 6, No. 4. pp. 544-547.
@article{8f61e554a98244c1844f7ab5c3dff29a,
title = "Four-year natural clinical course of pulmonary epithelioid hemangioendothelioma without therapy",
abstract = "Pulmonary epithelial hemangioendothelioma is a rare low to intermediate malignant vascular tumor originating from vascular endothelial cells. The therapy for this disease, if possible, is surgical resection. However, there is no standard treatment for patients with multiple unresectable lesions. We present the case of a 42-year-old woman treated with a natural clinical course of hemangioendothelioma for four years without therapy. The nodules have increased in number and size extremely slowly, and the patient is alive and asymptomatic four years after diagnosis.",
author = "Akira Haro and Genkichi Saitoh and Sadafumi Tamiya and Akira Nagashima",
year = "2015",
month = "7",
day = "1",
doi = "10.1111/1759-7714.12192",
language = "English",
volume = "6",
pages = "544--547",
journal = "Thoracic Cancer",
issn = "1759-7706",
publisher = "Blackwell Publishing Asia Pty Ltd",
number = "4",

}

TY - JOUR

T1 - Four-year natural clinical course of pulmonary epithelioid hemangioendothelioma without therapy

AU - Haro, Akira

AU - Saitoh, Genkichi

AU - Tamiya, Sadafumi

AU - Nagashima, Akira

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Pulmonary epithelial hemangioendothelioma is a rare low to intermediate malignant vascular tumor originating from vascular endothelial cells. The therapy for this disease, if possible, is surgical resection. However, there is no standard treatment for patients with multiple unresectable lesions. We present the case of a 42-year-old woman treated with a natural clinical course of hemangioendothelioma for four years without therapy. The nodules have increased in number and size extremely slowly, and the patient is alive and asymptomatic four years after diagnosis.

AB - Pulmonary epithelial hemangioendothelioma is a rare low to intermediate malignant vascular tumor originating from vascular endothelial cells. The therapy for this disease, if possible, is surgical resection. However, there is no standard treatment for patients with multiple unresectable lesions. We present the case of a 42-year-old woman treated with a natural clinical course of hemangioendothelioma for four years without therapy. The nodules have increased in number and size extremely slowly, and the patient is alive and asymptomatic four years after diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=84934294851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934294851&partnerID=8YFLogxK

U2 - 10.1111/1759-7714.12192

DO - 10.1111/1759-7714.12192

M3 - Article

AN - SCOPUS:84934294851

VL - 6

SP - 544

EP - 547

JO - Thoracic Cancer

JF - Thoracic Cancer

SN - 1759-7706

IS - 4

ER -